KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Hims & Hers Health (HIMS) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Hims & Hers Health (HIMS) over the last 6 years, with Q3 2025 value amounting to 2.65%.

  • Hims & Hers Health's EBITDA Margin fell 162700.0% to 2.65% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.08%, marking a year-over-year decrease of 21000.0%. This contributed to the annual value of 8.52% for FY2024, which is 112100.0% up from last year.
  • Latest data reveals that Hims & Hers Health reported EBITDA Margin of 2.65% as of Q3 2025, which was down 162700.0% from 7.98% recorded in Q2 2025.
  • In the past 5 years, Hims & Hers Health's EBITDA Margin registered a high of 18.92% during Q3 2024, and its lowest value of 98.38% during Q1 2021.
  • Over the past 5 years, Hims & Hers Health's median EBITDA Margin value was 3.51% (recorded in 2023), while the average stood at 9.73%.
  • As far as peak fluctuations go, Hims & Hers Health's EBITDA Margin crashed by -781700bps in 2021, and later soared by 821500bps in 2022.
  • Hims & Hers Health's EBITDA Margin (Quarter) stood at 36.89% in 2021, then skyrocketed by 83bps to 6.41% in 2022, then soared by 108bps to 0.51% in 2023, then skyrocketed by 941bps to 5.29% in 2024, then plummeted by -50bps to 2.65% in 2025.
  • Its EBITDA Margin was 2.65% in Q3 2025, compared to 7.98% in Q2 2025 and 8.47% in Q1 2025.